Glaukos
-$1.51 (-3.73%) Today
$0.00 (0.00%) As of 10:47 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.
About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
CEO
Thomas William Burns
Employees
727
Headquarters
San Clemente, California
Founded
1998
GKOS Key Statistics
Market cap
1.84B
Price-Earnings ratio
—
Dividend yield
—
Average volume
493.97K
High today
$40.03
Low today
$38.51
Open price
$39.88
Volume
407.75K
52 Week high
$87.24
52 Week low
$33.33
Analyst ratings
56%
of 9 ratings
Buy
33.3%
Hold
55.6%
Sell
11.1%
GKOS Earnings
-$0.50
-$0.33
-$0.17
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours